Alpha Orthopaedics, Inc.

Alpha Orthopaedics’ AT3™ System Receives CE Mark Certification, Further Prepares Alpha Orthopaedics to Enter World-Wide Markets

Alpha Orthopaedics’ innovative AT3™ System featuring RelēF Technology has received CE Mark. The FDA had previously cleared the AT3 System for commercial distribution in the U.S. RelēF Technology is used for the relief of pain associated with conditions such as tendinosis and fasciosis. This CE mark completes company’s preparation for global market launch, which included a successful completion of its pivotal trial and a side-by-side evaluation showing superiority over PRP. - October 17, 2012